PVLA
Palvella Therapeutics, Inc. Common Stock
PVLA
PVLA
76 hedge funds and large institutions have $165M invested in Palvella Therapeutics, Inc. Common Stock in 2021 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 17 increasing their positions, 17 reducing their positions, and 21 closing their positions.
Holders
76
Holders Change
+3
Holders Change %
+4.11%
% of All Funds
1.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
24
Increased
17
Reduced
17
Closed
21
Calls
$1.59M
Puts
$1.88M
Net Calls
-$287K
Net Calls Change
-$551K
Top Buyers
1 |
1
Invesco
Atlanta,
Georgia
|
$7.76M |
2 |
2
Two Sigma Investments
New York
|
$6.04M |
3 |
3
Two Sigma Advisers
New York
|
$5.76M |
4 |
MWNA
4
Marshall Wace North America
New York
|
$4.51M |
5 |
SCM
5
Soleus Capital Management
Greenwich,
Connecticut
|
$3.83M |